NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 82 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,688,445 | -18.5% | 534,318 | -0.2% | 0.00% | – |
| Q2 2023 | $2,071,484 | +68.0% | 535,267 | +20.3% | 0.00% | – |
| Q1 2023 | $1,232,830 | +54.4% | 445,065 | +0.3% | 0.00% | – |
| Q4 2022 | $798,462 | -15.5% | 443,590 | -0.4% | 0.00% | – |
| Q3 2022 | $945,000 | -21.8% | 445,374 | -0.9% | 0.00% | – |
| Q2 2022 | $1,209,000 | +98.5% | 449,598 | +220.4% | 0.00% | – |
| Q1 2022 | $609,000 | -18.6% | 140,324 | -2.8% | 0.00% | – |
| Q4 2021 | $748,000 | +34.5% | 144,347 | +59.4% | 0.00% | – |
| Q3 2021 | $556,000 | – | 90,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $47,848,000 | 7.75% |
| AMAZON COM INC | 1,457,055 | $14,716,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 1,500,000 | $15,150,000 | 3.76% |
| Affinity Asset Advisors, LLC | 900,000 | $9,090,000 | 3.25% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $20,200,000 | 1.32% |
| Perceptive Advisors | 17,822,302 | $180,004,000 | 1.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $8,080,000 | 0.55% |
| HILLMAN CO | 200,000 | $2,020,000 | 0.52% |
| RA Capital Management | 2,471,430 | $24,961,000 | 0.40% |
| Nantahala Capital Management | 1,190,810 | $12,027,000 | 0.34% |